Alivus Life Sciences
NSEI:ALIVUS
Rp 980,80
Rp-3,95 (-0,40%)
980,80 Rp
Rp-3,95 (-0,40%)
End-of-day quote: 03/30/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

Rp39,52
Earnings Per Share
Rp194,80
Revenue Per Share
0,00%
Gross Margin %
Rp120,87 B
Market Cap
Rp0,00 B
Long-Term Debt
Earnings Per Share
Rp39,52
Revenue Per Share
Rp194,80
Gross Margin %
0,00%
Market Cap
Rp120,87 B
Long-Term Debt
Rp0,00 B

Financials

Year Year 2025 2024 2023 2022
EPS Earnings Per Share Rp39,52 Rp39,52 Rp38,11 Rp35,63
Earnings Earnings Rp4,84B Rp4,84B Rp4,67B Rp4,37B
RPS Revenue Per Share Rp194,78 Rp194,80 Rp176,38 Rp174,48
Revenue Revenue Rp23,87B Rp23,87B Rp21,61B Rp21,38B
OCF Operating Cash Flow Rp3,92B Rp3,92B Rp3,13B Rp5,98B
FCF Free Cash Flow Rp2,25B Rp2,85B Rp0,00M Rp0,00M
OM Operating Margin 0,00% 0,00% 0,00% 0,00%
GM % Gross Margin % 0,00% 0,00% 0,00% 0,00%
FCFS Free Cash Flow Per Share Rp0,00 Rp0,00 Rp0,00 Rp0,00
LT Debt Long-Term Debt N/A N/A N/A N/A
Sha. Stocks 122,54M 122,53M 122,53M 122,53M
×